Entelos
San Mateo
About Entelos
Entelos is the leading provider of predictive biosimulation for drug discovery and development. We provide advanced biosimulation capabilities that make discovery more efficient and increase clinical success. For over 15 years, we have enabled R&D organizations to predict better paths to success by simulating systems biology. Our solutions include mechanism-based, mathematical models; virtual patients and populations; biosimulation software; and biosimulation expertise.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Total funding: $39.6M
- Funding stage: M&A
- Last round: Post-IPO Equity (Jun 2013)
- Ticker: lse:ENTL
- Website: entelos.com
- Phone: +1 650-572-5400
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/entelos-2711321 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.